Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05609279 · ClinicalTrials.gov registry record
Metabolic Phenotypes and Heterogeneity in Disease Burden Risk in Type 1 Diabetes
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 60
- Enrollment target
NCT05609279: Completed study, sponsored by University of Michigan.
NCT05609279 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05609279 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This study focuses on individuals with type 1 diabetes (T1D) and seeks to comprehensively study and understand several aspects of T1D including: susceptibility to hypoglycemia (low blood sugar) and improvement in hypoglycemia risk using of advanced diabetes technologies, such as continuous glucose monitoring (CGM); the differences among individuals with T1D in the risk of chronic complications, and minimize the psychosocial impact of T1D.
Primary Outcome
Metabolomic samples will be requested from all study participants at the first (Visit 1) and last (Visit 3) study visit. The last study visit will be within 3 years of the first.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-02-18 |
| Est. Completion | 2024-08-30 |
What the finished NCT05609279 record still lists
NCT05609279 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05609279 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05609279 about?
NCT05609279 is a clinical study titled "Metabolic Phenotypes and Heterogeneity in Disease Burden Risk in Type 1 Diabetes". This study focuses on individuals with type 1 diabetes (T1D) and seeks to comprehensively study and understand several aspects of T1D including: susceptibility to hypoglycemia (low blood sugar) and improvement in hypoglycemia risk using of advanced diabetes technologies, such as continuous glucose m...
What is the current status of trial NCT05609279?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2021-02-18. Estimated completion is 2024-08-30.
Who is sponsoring clinical trial NCT05609279?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI